Ahmedabad based Troikaa Pharmaceuticals Limited has received recognition for its in-house research & development facility from the department of scientific and industrial research (DSIR) under the ministry of science and technology.

“This accreditation speaks of Troikaa's excellent track record of research work on new drug delivery system & the stupendous infrastructure available,” said Mr. Ketan Patel, Managing Director, Troikaa Pharmaceuticals.

The research & development(R&D) centre currently focuses on manufacturing high quality Critical care Injectibles, Tablets and Topical preparations through proprietary technology platforms like Lipisol (enables oily formulation become water miscible), Matrix (sustained release of small amounts of active ingredient in controlled manner over an extended period of time from the tablet) and many more. The formulations developed from these platforms are unique as well as superior to conventional formulations available in the market.

It is through this R&D facility and a very dedicated team that Troikaa could develop Aquatech Technology. It is with this technology that Troikaa developed world’s first ever painless Diclofenac 1ml i.e. painkiller injection called DYNAPAR AQ.

Troikaa enjoys an Indian Patent of the 1ml Diclofenac ampoule and is seeking a patent in another 107 countries across the world.

Troikaa’s forte has been R&D and their focus area right from the beginning has been to address unmet medical needs through New Drug Delivery Systems. “It is our promise to provide best of technology that confers new benefits upon needy patients. DYNAPAR AQ 1ml sales of over 1 Lac ampoules proves, that we are on the right path” says, Mr. Ketan Patel.

As a result of this latest recognition, the in-house R&D unit of Troikaa would be eligible for corporate tax exemptions against the expenditure incurred on R&D activities; giving it a further boost. Also it would help to enhance the export of its innovative products.

- End -

About Troikaa Pharmaceuticals

Troikaa Pharmaceuticals is a 105 crore fast growing healthcare company based in Ahmedabad that commenced its commercial activities in the year 1984. Dedicated to improving human life, the company develops, manufactures and markets superior products and services that improve the quality of life and satisfy customer needs. The company is constantly striving towards attaining technology breakthroughs, which are in accordance with its promise of providing better treatment options and drug delivery systems to the people in India and aboard.

The company holds unique, patented technology platforms for various Novel Drug Delivery Systems - Intra-oral, Oral, Parenteral, Sustain Release & Topical. It has two manufacturing facilities located in Ahmedabad and Dehradun (Uttaranchal). The Ahmedabad facility located at Thol; an industrial area which is 25 Kilometers from Ahmedabad has capability to manufacture high quality Critical Care Injectables, Tablets and Topical preparations.

Troikaa’s state-of-the-art manufacturing facilities are certified by the World Health Organization for following Good Manufacturing Practices and its Quality Management Systems certified by KVQA to follow ISO 9001:2000 standards for manufacturing and supply of Drugs and Pharmaceuticals.

About DSIR:

The Department of Scientific and Industrial Research (DSIR) is a part of the Ministry of Science and Technology, Govt. of India, which was announced through a presidential Notification dated January 4, 1985 (74/2/1/8Cab). The DSIR is responsible for the implementation of the Plan scheme “Technology Promotion, Development and Utilization (TDPU)” apart from coordinating the activities of the Council of Scientific and Industrial Research (CSIR) and Public enterprises.